Huiming Zhao

3PUBLICATIONS
29CO-AUTHORS
Molecular targetsCancer cell biologyChemotherapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (3)

|Jul 23, 2026
Non-kinase Orchestrated VEGFR2-ERK Signaling is a Dependency and Pharmacological Target for Antiangiogenic Immunotherapy.

|Sep 23, 2024
Targeting SHCBP1 Inhibits Tumor Progression by Restoring Ciliogenesis in Ductal Carcinoma.

Wengui Shi, Lianshun Li, Huiming Zhao

|Aug 30, 2023
PICH Activates Cyclin A1 Transcription to Drive S-Phase Progression and Chemoresistance in Gastric Cancer.

Huili Ye, Wengui Shi, Jing Yang

Pageof 1

Frequent Collaborators

3 joint publications

Wengui Shi

3 joint publications

Long Qin

3 joint publications

Zuoyi Jiao

3 joint publications

Zeyuan Yu